发明名称 Antagonists of activin-actriia and uses for increasing red blood cell levels
摘要 In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.
申请公布号 US8895016(B2) 申请公布日期 2014.11.25
申请号 US200912459188 申请日期 2009.06.26
申请人 Acceleron Pharma, Inc. 发明人 Sherman Matthew L.;Seehra Jasbir;Borgstein Niels
分类号 A61K39/00;A61K38/00;A61K38/17;C07K14/71;A61K38/22 主分类号 A61K39/00
代理机构 Ropes & Gray LLP 代理人 Ropes & Gray LLP
主权项 1. A method for treating anemia in a patient, the method comprising administering to a patient in need thereof an effective amount of an ActRIIa polypeptide selected from the group consisting of: a) a polypeptide comprising an amino acid sequence at least 95% identical to SEQ ID NO: 2; b) a polypeptide comprising an amino acid sequence at least 95% identical to SEQ ID NO: 3; c) a polypeptide comprising an amino acid sequence at least 95% identical to SEQ ID NO: 7; d) a polypeptide comprising an amino acid sequence at least 95% identical to SEQ ID NO: 12; and e) a polypeptide comprising an amino acid sequence that is encoded by a nucleic acid that hybridizes to the complement of SEQ ID NO:5 in the presence of 6.0 sodium/sodium citrate (SSC) at 45° C. followed by a wash in 2.0 SSC at 45° C., andwherein the ActRIIa polypeptide binds to activin.
地址 Cambridge MA US
您可能感兴趣的专利